Ipamorelin vs MK-677: which is better?
Ipamorelin (injectable) produces pulsatile GH release mimicking natural physiology. MK-677 (oral ibutamoren) produces continuous GH elevation. Ipamorelin is cleaner on side effects but requires daily injections; MK-677 is oral and convenient but causes significant water retention, appetite increase, and insulin resistance that ipamorelin doesn't.
The Core Difference
- Ipamorelin: injectable GHRP (growth hormone-releasing peptide); produces pulsatile GH release similar to natural secretion patterns
- MK-677 (Ibutamoren): oral non-peptide ghrelin mimetic; produces continuous GH elevation over 24 hours
Both ultimately increase GH and IGF-1 but through dramatically different pharmacological profiles.
Administration
Ipamorelin
- Subcutaneous injection
- 1–3 times daily
- Requires reconstitution, refrigeration
- Needles, syringes, alcohol swabs
MK-677
- Oral capsule or liquid
- Once daily (typically morning or bedtime)
- No injection required
- Longer shelf-life, easier travel
Pulsatile vs Continuous GH Release
This matters more than convenience:
Pulsatile (natural-mimicking) — ipamorelin
- Mimics normal GH secretion patterns
- Receptors maintain sensitivity
- Physiologically cleaner
- Less feedback suppression of endogenous GH
Continuous (constant elevation) — MK-677
- 24-hour GH/IGF-1 elevation
- Higher cumulative exposure
- More receptor desensitization potential
- Greater side effect burden (see below)
Side Effect Comparison
Ipamorelin
- Mild injection site reactions
- Transient water retention (usually resolves)
- Minor headaches initially
- Small blood sugar effects
- Generally well-tolerated long-term
MK-677
- Significant water retention (often several pounds)
- Persistent increased appetite (ghrelin mimetic effect is stronger than ipamorelin)
- Noticeable insulin resistance — often meaningful glucose and HbA1c rises
- Lethargy and fatigue in many users
- Joint stiffness from edema
- Sleep effects mixed — some report vivid dreams
Regulatory Status
Ipamorelin
- Compounded peptide
- Not FDA-approved
- Available through 503A compounding pharmacies with prescription
MK-677
- Was in clinical trials but not FDA-approved
- Sold as a "research chemical" in the US
- Legal gray zone — technically not for human consumption, widely used
- Quality control varies dramatically across vendors
Cost Comparison
Ipamorelin
- $150–$300/month legitimate
- $250–$500 with CJC-1295 stack
MK-677
- $30–$80/month from research chemical vendors
- Often dramatically cheaper than ipamorelin
- But quality verification is harder
Effectiveness Comparison
IGF-1 elevation
- MK-677 produces larger absolute IGF-1 rises (often 40–60% above baseline)
- Ipamorelin produces modest IGF-1 rises (typically 20–40%)
GH pulses
- Ipamorelin produces discrete GH pulses timed to injections
- MK-677 produces elevated baseline with enhanced natural pulses
Body composition effects
- MK-677 users often gain weight (3–5 lbs) from increased appetite and water
- Ipamorelin users may modestly reduce weight and visceral fat
- Both can support lean mass preservation during training
Sleep improvement
- Both can improve sleep quality
- MK-677 particularly associated with deep sleep improvements and vivid dreams
- Ipamorelin sleep effects are more modest
Who Should Choose Ipamorelin
- Pre-diabetic or diabetic users (insulin resistance concerns)
- Those wanting fat loss rather than weight gain
- Users prioritizing clean side effect profile
- Those comfortable with injection
- Older adults sensitive to edema
- Those using peptide stacks (ipamorelin integrates well)
Who Should Choose MK-677
- Hard gainers trying to add muscle mass (appetite stimulation helps)
- Those prioritizing deep sleep improvement
- Users unwilling to inject
- Budget-constrained users
- Younger users without diabetes risk
- Short-term use (not indefinite)
Who Should Avoid Both
- Active cancer or cancer history
- Uncontrolled diabetes
- Proliferative diabetic retinopathy
- Pregnancy
- Critical illness
Practical Protocols
Ipamorelin standard
- 200–300 mcg subq 2–3× daily
- One dose before bed is critical
- 12-week cycles, 4 weeks off
MK-677 standard
- 12.5–25 mg oral once daily
- Morning or evening (user preference)
- 8–16 week cycles, 4–8 weeks off
Can You Stack Them?
Theoretically yes, but redundant for most users. Both raise GH/IGF-1 through overlapping mechanisms. Side effects compound. Most practitioners recommend choosing one rather than stacking.
Long-Term Use Considerations
Ipamorelin
- Cycle-based use for years appears well-tolerated
- Side effect burden stays manageable
- Receptor desensitization less problematic
MK-677
- Continuous exposure may cause more receptor adaptation
- Water retention and insulin resistance tend to persist
- Many users cycle off after 8–16 weeks
What If You're Unsure?
Start with ipamorelin. Cleaner side effect profile means lower risk. If effectiveness is underwhelming after a full cycle, you can try MK-677 knowing what "on a GH secretagogue" feels like in your body. The reverse order is harder because MK-677's side effects (water, appetite) can mask or mimic genuine effects.
Bottom Line
Ipamorelin is cleaner, more physiological, but more expensive and requires injection. MK-677 is cheaper, oral, and often feels more dramatic — but brings significant water retention, appetite increase, and insulin resistance. For most mature users pursuing anti-aging or body composition goals, ipamorelin is the better long-term choice.
See the ipamorelin guide. Related: vs sermorelin, side effects.
Sources
- Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998
- Copinschi G et al. Effects of a 7-day treatment with MK-677 on slow-wave sleep in older adults. J Clin Endocrinol Metab 1997
- Kargi AY, Merriam GR. Adult Growth Hormone Deficiency: Clinical Manifestations and Treatment (review). Endotext 2023
Related questions about Ipamorelin
Find a Ipamorelin provider
Browse verified providers offering Ipamorelin therapy. Filter by telehealth, location, and insurance acceptance.
Browse providersMedical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.